Showing results (141-150 of 219) with videos related to
Sort By:
Pageof 22
Allergologia Et Immunopathologia|September 1, 1991
Topical flunisolide treatment of perennial rhinitis: clinical and immunological effectsR Paganelli, I Quinti, A di Sabatino, et al.The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapyM Carlesimo, M L Bernardi, G Mattiacci, et al.Antiviral Research|May 16, 2000
The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2. IRHAN Study GroupF Dianzani, G Antonelli, F Aiuti, et al.Annals of Ophthalmology|June 1, 1985
Thymic factor therapy for herpetic keratitisP Pivetti-Pezzi, P De Liso, S Tamburi, et al.Blood Cells|January 1, 1991
Suicide behavior of target cells after binding with natural killer cellsG Arancia, M C Sirianni, W Malorni, et al.Clinical Immunology (Orlando, Fla.)|February 29, 2000
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAARTF Pandolfi, M Pierdominici, M Marziali, et al.Clinical and Experimental Immunology|May 1, 1993
Increased IL-6 gene expression and production in patients with common variable immunodeficiencyF Pandolfi, R Paganelli, A Oliva, et al.Diagnostic Immunology|January 1, 1986
Immunological responses of patients with recurrent herpes genitalisM C Sirianni, R Bonomo, B Scarpati, et al.Clinical and Experimental Immunology|October 30, 1999
CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapyA Giovannetti, F Ensoli, F Mazzetta, et al.Pageof 22